Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
about
Biology of recently discovered cytokines: interleukin-17--a unique inflammatory cytokine with roles in bone biology and arthritisThe role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models.The interleukin-17 cytokine family: critical players in host defence and inflammatory diseasesThe biological functions of T helper 17 cell effector cytokines in inflammationIL-17RC: a partner in IL-17 signaling and beyondDistinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expressionIncreased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaB-dependent pathway in patients with rheumatoid arthritisSecukinumab for rheumatology: development and its potential place in therapyEnigma of IL-17 and Th17 Cells in Rheumatoid Arthritis and in Autoimmune Animal Models of ArthritisAdvances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple SclerosisAnimal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside-a Comprehensive ReviewT Cell Migration in Rheumatoid ArthritisInterleukin-23: as a drug target for autoimmune inflammatory diseasesThe therapeutic potential of RORγ modulators in the treatment of human diseaseClinical biomarkers and pathogenic-related cytokines in rheumatoid arthritisInterleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritisA selective inhibitor reveals PI3Kγ dependence of T(H)17 cell differentiationThe IL-17 pathway as a major therapeutic target in autoimmune diseasesA knowledgebase resource for interleukin-17 family mediated signalingExposure to Candida albicans polarizes a T-cell driven arthritis model towards Th17 responses, resulting in a more destructive arthritisEnhanced Th17-cell responses render CCR2-deficient mice more susceptible for autoimmune arthritisIL-23 drives a pathogenic T cell population that induces autoimmune inflammationMyeloid-derived suppressor cells are proinflammatory and regulate collagen-induced arthritis through manipulating Th17 cell differentiation.Location of CD4+ T cell priming regulates the differentiation of Th1 and Th17 cells and their contribution to arthritis.IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.Bacterial invasion and persistence: critical events in the pathogenesis of periodontitis?Commercial bovine proteoglycan is highly arthritogenic and can be used as an alternative antigen source for PGIA model.Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study.Interleukin-10 attenuation of collagen-induced arthritis is associated with suppression of interleukin-17 and retinoid-related orphan receptor γt production in macrophages and repression of classically activated macrophages.Role of SFB in autoimmune arthritis: an example of regulation of autoreactive T cell sensitivity in the gutIL-17-mediated monocyte migration occurs partially through CC chemokine ligand 2/monocyte chemoattractant protein-1 induction.CCR5 dictates the equilibrium of proinflammatory IL-17+ and regulatory Foxp3+ T cells in fungal infection.The mediation of interleukin-17 and chemokine ligand 2 in pelvic pain of experimental autoimmune prostatitis.Low CD4/CD8 T-cell ratio associated with inflammatory arthropathy in human T-cell leukemia virus type I Tax transgenic mice.Bone damage in rheumatoid arthritis: mechanistic insights and approaches to preventionCritical role of TCF-1 in repression of the IL-17 gene.The role of interleukin-17 in bone metabolism and inflammatory skeletal diseases.IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis?Overexpression of a minimal domain of calpastatin suppresses IL-6 production and Th17 development via reduced NF-κB and increased STAT5 signalsInterleukin (IL)-17A, F and AF in inflammation: a study in collagen-induced arthritis and rheumatoid arthritis.
P2860
Q21195672-9BBF6084-E9C2-46FC-BE16-741381590821Q24519770-1434B2FF-5CCE-4392-82DC-D4F05E8AD9B3Q24594675-BC7817D6-7214-4165-8ADD-D03B45DC9528Q24614431-02FB289B-938B-4320-B88C-D89CC14294B6Q24629783-4E4F5BF6-7A37-4505-9558-01CA415A4D7AQ24674584-34203A99-E399-4287-8DA2-F16D632B632EQ24799278-7937976C-DE09-4455-9CC4-6BBF9611DE0CQ26738523-C5B11335-E583-4190-B737-ECF85E155FDBQ26768254-D636FA8C-65B8-4308-BF58-F6D96331DA80Q26771957-D1FB72C4-0809-4B3D-B248-AB08FF2C4E0AQ26774874-863A2804-93C0-41DD-ADFD-B3EB8E872D67Q26797338-A66F0336-023F-4CD0-9A75-AED98FB2FC90Q27009502-FF10FFFE-B01D-4232-93D4-C2A85EF8CD1EQ27022108-87D834D2-8739-490F-BF70-A81E1C7B6BF4Q27022559-7FDEDA52-9C7B-45D5-AF53-288EFF1FB419Q27023777-37524E5F-CA3B-4FB0-B002-22DFD58DCE8DQ27678799-9C8A6C74-224A-4220-8D38-6819323E97CDQ28300826-AEC63FD9-544C-4A45-94B1-862BF9664846Q28607319-3DA26EC9-5C98-4872-BB26-28F341AC4BDEQ28728570-DFE1C563-DD30-4DF5-884A-D532F849FDEFQ28744262-0A7F36BE-29C5-4FB7-B855-903FFEB6D935Q29547525-F7EC134B-7E4D-4659-BA40-0FF79C88534BQ30300780-D30FCDB5-D2DD-4BD4-AABD-5DA820E0D1D7Q30412824-7166FF17-BFB5-4974-B671-9F681245636FQ30438358-14C16207-C42D-4BCC-8895-3E4578FDF383Q33359654-C64B61D8-F5B0-4D5B-96C5-38A04B4C4E1BQ33757939-F2D9A25C-1C32-4C2C-96E1-08A2157CE93CQ33764331-2B3CC0E2-E0AE-439C-8B19-8005FD14BC30Q33767035-E4EC8441-25E1-4D09-A212-B88BE4D1ACE2Q33779273-D1D173F6-FD7E-46B4-9966-95FBA2D4D813Q33807584-B8616FCC-E442-42BF-B02F-61DE74E4933FQ33839741-21D283B9-3F71-41C7-A192-DED1A5711FB0Q33847239-0698E559-0B6C-4053-BC33-E4EC7D1F9B87Q33869511-226A6C1E-43A4-4A94-A057-5DA25EDD61D7Q34001621-BF6E7331-63A8-4F78-923B-FB6750A67D3EQ34026243-93862E70-6462-4E27-982B-3B934DB194CFQ34049252-8997E56B-BB37-41E8-80EC-0CDA339F8648Q34062484-EC06AA13-F3BE-4EC2-A787-C0026187E703Q34064908-33B9FC9C-DF89-41C2-9C35-234C73B5F1E9Q34065372-E72C8C1E-A680-49AD-BE46-BF5BDEF081AB
P2860
Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Treatment with a neutralizing ...... destruction, and bone erosion.
@en
type
label
Treatment with a neutralizing ...... destruction, and bone erosion.
@en
prefLabel
Treatment with a neutralizing ...... destruction, and bone erosion.
@en
P2093
P356
P1476
Treatment with a neutralizing ...... destruction, and bone erosion.
@en
P2093
Birgitte Oppers-Walgreen
Christina J J Coenen-de Roo
Erik Lubberts
Leo A B Joosten
Liduine van den Bersselaar
Wim B van den Berg
P304
P356
10.1002/ART.20001
P577
2004-02-01T00:00:00Z